• SENSEX 82,146.25
    704.21 (+0.86%)
  • BANKNIFTY 55,760.85
    84.00 (+0.15%)
  • Cochin Shipyard
    2,547.25 2,977.10(%)
  • Azad Engineering
    1,561.00 1,128.40(%)
  • Reliance Industr
    1,451.35 1,608.95(%)
  • Garden Reach Sh.
    3,264.60 1,148.10(%)
  • HDFC Bank
    1,996.30 1,977.95(%)
  • Reliance Power
    63.13 63.39(%)
  • HFCL
    91.66 171.00(%)
  • Ramkrishna Forg.
    674.40 1,064.00(%)
  • Suzlon Energy
    66.10 45.13(%)
  • Sika Interplant
    1,485.35 1,350.35(%)
  • Multi Comm. Exc.
    7,529.95 7,138.00(%)
  • Mazagon Dock
    3,380.30 1,200.00(%)
  • St Bk of India
    816.45 898.80(%)
  • IDFC First Bank
    72.25 84.50(%)
  • Hindustan Zinc
    509.55 717.10(%)
  • Brainbees Solut.
    431.90 734.25(%)
  • Eternal Ltd
    264.10 304.50(%)
  • REC Ltd
    416.45 653.90(%)
  • ICICI Bank
    1,461.95 1,471.10(%)
  • RBL Bank
    218.80 270.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astonea Labs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 93643.0
  • ISIN : INE0TG901011
135.50 1 (0.37%)
  • As on 06 Jun 2025 (EOD)
  • Today’s Low

    135.00
  • Today’s High

    137.00
  • Open

    137.00
  • Perv Close

    135.00
  • 52W Low

    135.00
  • 52W High

    140.00

Key Indicators

  • P/E(TTM)

    37.43

  • Mar.Cap (₹Cr.)

    142.42

  • Div & Yield %

    0.00

  • Book Value(₹)

    48.37

  • Debt-Equity Ratio

    0.37

  • AGM Date

    05-Jun-2025

  • EPS

    3.62

  • P/E Ratio

    37.43

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    142.42

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.51

  • BV (₹)

    48.40

  • Sales( ₹ in Cr.)

    80.19

  • NP (in Cr.)

    3.81

  • NP Var(%)

    550.0

  • Div%

    0.0

  • CPS (₹)

    7.40

  • EPS (₹)

    3.60

  • Traded Value (₹ in Lakhs)

    142.42

  • 52 Week High

    140.00

  • 52 Week Low

    135.00

  • Price BSE

    136.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    142.42

  • P/C Ratio

    18.40

  • P/E Ratio

    37.50

  • Price Vs.BV

    3.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar
INCOME :            
Sales Turnover 80.19 67.05 30.06 - - -
Excise Duty 0.00 0.00 0.00 - - -
Net Sales 80.19 67.05 30.06 - - -
Other Income 0.10 0.21 0.12 - - -
Stock Adjustments 2.11 2.47 -0.57 - - -
Total Income 82.40 69.73 29.61 - - -
EXPENDITURE :            
Raw Materials 58.49 52.53 18.49 - - -
Power and Fuel Cost 1.22 0.86 0.39 - - -
Employee Cost 5.03 3.26 1.88 - - -
Other Manufacturing Expenses 3.06 3.91 1.41 - - -
Selling and Administration Expenses 2.35 1.82 1.41 - - -
Miscellaneous Expenses 0.19 0.00 0.08 - - -
Employee Benefit Expenses 5.03 3.26 1.88 - - -
Less: Preoperative Expenditure 0.00 0.00 0.00 - - -
Total Expenses 70.35 62.38 23.66 - - -
Operating Profit 12.05 7.35 5.95 - - -
Interest 2.97 2.34 1.58 - - -
Gross Profit 9.08 5.01 4.37 - - -
Depreciation 3.97 3.93 3.79 - - -
Profit Before Tax 5.11 1.08 0.58 - - -
Current Tax 1.63 0.57 0.31 - - -
Fringe Benefit tax 0.00 0.00 0.00 - - -
Deferred Tax -0.33 -0.15 0.02 - - -
Reported Net Profit 3.81 0.67 0.25 - - -
Extraordinary Items 0.00 0.08 0.00 - - -
Adjusted Net Profit 3.81 0.59 0.25 - - -
Adjustment below Net Profit -3.60 0.00 0.12 - - -
P & L Balance brought forward 4.16 3.49 3.12 - - -
Statutory Appropriations 0.00 0.00 0.00 - - -
Appropriations 0.00 0.00 0.00 - - -
P & L Balance carried down 4.37 4.16 3.49 - - -
Dividend 0.00 0.00 0.00 - - -
Preference Dividend 0.00 0.00 0.00 - - -
Equity Dividend (%) 0.00 0.00 0.00 - - -
Dividend Per Share(Rs) 0.00 0.00 0.00 - - -
Earnings Per Share-Unit Curr 5.01 1.66 0.62 - - -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 15.75 20.39 18.73 - - -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    72.30%

  • Public Share Holding

    27.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 7,599,970 72.30 7,599,970 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,599,970 72.30 7,599,970 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 842,000 8.01 842,000 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 224,000 2.13 224,000 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,066,000 10.14 1,066,000 7
2] Non Institution
Bodies Corporate 295,000 2.81 295,000 3
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 5,000 0.05 5,000 5
Foreign Non Institution Other 4,000 0.04 4,000 4
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 194,000 1.85 194,000 3
Individuals holding nominal share capital up to Rs. 1 lakh 1,093,030 10.40 1,093,030 987
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 254,000 2.42 254,000 1
Sub Total 1,845,030 17.55 1,845,030 1,003
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,511,000 100.00 10,511,000 1,014

Company Background

Astonea Labs LtdPharmaceuticals - Indian - Bulk Drugs

  • Astonea Labs Ltd
  • BSE Code : 93643.0
  • ISIN : INE0TG901011
  • Incorporation Year

    2017

  • Registered Office

    H.No.1358 1st Floor Sector-22B
    , Chandigarh,
    Chandigarh-160022

  • Telephone

    +91-98883 02323

  • FAX

  • Chairman

  • Managing Director

    Ashish Gulati

  • Company Secretary

    Avneet Kaur

  • Auditor

    Avnish Sharma & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Astonea Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astonea Labs 135.50 80.29 80.19 37.43 16.33
Abbott India 31,699.95 6,097.18 5,848.91 47.62 44.71
Astrazeneca Phar 9,891.10 1,330.33 1,295.53 213.63 33.26
P & G Health Ltd 5,576.75 1,166.89 1,151.26 36.85 39.76
Glaxosmi. Pharma 3,459.70 3,866.05 3,723.49 63.77 58.72
Cipla 1,489.65 17,645.00 16,574.34 23.33 20.10
Amrutanjan Healt 723.80 437.58 421.23 41.17 20.84
Guj. Themis Bio. 329.70 174.19 169.82 73.59 44.82
Fermenta Biotec. 323.00 315.24 307.09 14.06 4.10
Bliss GVS Pharma 139.55 638.96 605.46 21.31 11.19
Ambalal Sarabhai 36.84 11.70 3.81 34.11 1.92